Skip to main content
Top
Published in: BMC Infectious Diseases 1/2020

Open Access 01-12-2020 | Research article

Assessing the effectiveness of Chagas disease education for healthcare providers in the United States

Authors: Paula Stigler Granados, Gerardo J. Pacheco, Evangelina Núñez Patlán, Jose Betancourt, Lawrence Fulton

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Chagas disease is a zoonotic infection caused by the parasite Trypanosoma cruzi, which affects an estimated 8–11 million people globally. Chagas disease is almost always associated with poverty in rural areas and disproportionately impacts immigrants from Latin America living in the United States. Approximately 20–30% of people who are infected with Chagas disease will develop a chronic form of the infection that can be fatal if left untreated. Chagas disease is vastly underestimated in the United States, often goes undiagnosed and is not well understood by most U.S. healthcare providers. One of the most important ways at reducing barriers to improving diagnostics of Chagas disease in the U.S. is giving healthcare providers the most up-to-date information and access to leading experts.

Methods

An online webinar was conducted for healthcare providers, veterinarians and public health professionals using Chagas disease expert panelists. Pre and post tests were administered to participants (n = 57) to determine the efficacy in raising awareness and to determine key focus areas for improving knowledge. A Wilcoxon rank-sum was used for non-parametric variables equivalent and for questions that assessed knowledge the McNemar’s Chi-Square test was used.

Results

There were statistically significant learning increases in multiple categories including transmission (p = <.001), clinical presentation (p = 0.016), diagnostics (p = <.001), and treatment (p = <.001).

Conclusion

Providing easily accessible learning opportunities using validated testing and evaluations should be further developed for rural healthcare providers in the U.S. as well as healthcare providers serving under represented populations such as immigrants. There is a clear lack of knowledge and awareness surrounding Chagas disease in the United States and just by raising awareness and providing education on the topic, lives will be saved.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev. 2011;24(4):655–81.CrossRef Bern C, Kjos S, Yabsley MJ, Montgomery SP. Trypanosoma cruzi and Chagas' disease in the United States. Clin Microbiol Rev. 2011;24(4):655–81.CrossRef
2.
go back to reference Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49(5):e52–e4. Bern C, Montgomery SP. An estimate of the burden of Chagas disease in the United States. Clin Infect Dis. 2009;49(5):e52–e4.
3.
go back to reference Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the burden of Chagas disease in the United States. PLoS Neglect Trop Dis. 2016;10(11). Manne-Goehler J, Umeh CA, Montgomery SP, Wirtz VJ. Estimating the burden of Chagas disease in the United States. PLoS Neglect Trop Dis. 2016;10(11).
4.
go back to reference Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hygiene. 2015;93(1):108–13.CrossRef Manne-Goehler J, Reich MR, Wirtz VJ. Access to care for Chagas disease in the United States: a health systems analysis. Am J Trop Med Hygiene. 2015;93(1):108–13.CrossRef
5.
go back to reference Montgomery SP, Starr MC, Cantey PT, Edwards MS, Meymandi SK. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hygiene. 2014;90(5):814–8.CrossRef Montgomery SP, Starr MC, Cantey PT, Edwards MS, Meymandi SK. Neglected parasitic infections in the United States: Chagas disease. Am J Trop Med Hygiene. 2014;90(5):814–8.CrossRef
6.
go back to reference Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13(4):342–8.CrossRef Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: a computational simulation model. Lancet Infect Dis. 2013;13(4):342–8.CrossRef
7.
go back to reference Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115(1–2):14–21.CrossRef Schmunis GA, Yadon ZE. Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop. 2010;115(1–2):14–21.CrossRef
8.
go back to reference Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin N Am. 2012;26(2):275–91.CrossRef Rassi A Jr, Rassi A, Marcondes de Rezende J. American trypanosomiasis (Chagas disease). Infect Dis Clin N Am. 2012;26(2):275–91.CrossRef
9.
go back to reference Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. Jama. 2007;298(18):2171–81.CrossRef Bern C, Montgomery SP, Herwaldt BL, Rassi A, Marin-Neto JA, Dantas RO, et al. Evaluation and treatment of Chagas disease in the United States: a systematic review. Jama. 2007;298(18):2171–81.CrossRef
10.
go back to reference Marin-Neto JA, Simões MV, Sarabanda ÁVL. Chagas' heart disease. Arq Bras Cardiol. 1999;72(3):247–80.CrossRef Marin-Neto JA, Simões MV, Sarabanda ÁVL. Chagas' heart disease. Arq Bras Cardiol. 1999;72(3):247–80.CrossRef
11.
go back to reference Manne JM, Snively CS, Ramsey JM, Salgado MO, Bärnighausen T, Reich MR. Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis. 2013;7(10):e2488.CrossRef Manne JM, Snively CS, Ramsey JM, Salgado MO, Bärnighausen T, Reich MR. Barriers to treatment access for Chagas disease in Mexico. PLoS Negl Trop Dis. 2013;7(10):e2488.CrossRef
12.
go back to reference Forsyth CJ, Granados PS, Pacheco GJ, Betancourt JA, Meymandi SK. Current gaps and needs for increasing access to healthcare for people with Chagas disease in the USA. Curr Trop Med Rep. 2019;6(1):13–22.CrossRef Forsyth CJ, Granados PS, Pacheco GJ, Betancourt JA, Meymandi SK. Current gaps and needs for increasing access to healthcare for people with Chagas disease in the USA. Curr Trop Med Rep. 2019;6(1):13–22.CrossRef
13.
go back to reference Moncayo Á, Silveira AC. Current epidemiological trends of Chagas disease in Latin America and future challenges: Epidemiology, surveillance, and health policies. American Trypanosomiasis Chagas Disease: Elsevier; 2017. p. 59–88. Moncayo Á, Silveira AC. Current epidemiological trends of Chagas disease in Latin America and future challenges: Epidemiology, surveillance, and health policies. American Trypanosomiasis Chagas Disease: Elsevier; 2017. p. 59–88.
14.
go back to reference Meymandi SK, Forsyth CJ, Soverow J, Hernandez S, Sanchez D, Montgomery SP, et al. Prevalence of Chagas disease in the Latin American–born population of Los Angeles. Clin Infect Dis. 2017;64(9):1182–8.CrossRef Meymandi SK, Forsyth CJ, Soverow J, Hernandez S, Sanchez D, Montgomery SP, et al. Prevalence of Chagas disease in the Latin American–born population of Los Angeles. Clin Infect Dis. 2017;64(9):1182–8.CrossRef
15.
go back to reference Lynn MK, Bossak BH, Sandifer PA, Watson A, Nolan MS. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205:105361.CrossRef Lynn MK, Bossak BH, Sandifer PA, Watson A, Nolan MS. Contemporary autochthonous human Chagas disease in the USA. Acta Trop. 2020;205:105361.CrossRef
16.
go back to reference Klotz SA, Dorn PL, Mosbacher M, Schmidt JO. Kissing bugs in the United States: risk for vector-borne disease in humans. Environmental health insights. 2014;8:EHI.S16003.CrossRef Klotz SA, Dorn PL, Mosbacher M, Schmidt JO. Kissing bugs in the United States: risk for vector-borne disease in humans. Environmental health insights. 2014;8:EHI.S16003.CrossRef
17.
go back to reference Cantey PT, Stramer SL, Townsend RL, et al. The United States trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes chagas disease among United States blood donors: transfusion; 2012.CrossRef Cantey PT, Stramer SL, Townsend RL, et al. The United States trypanosoma cruzi infection study: evidence for vector-borne transmission of the parasite that causes chagas disease among United States blood donors: transfusion; 2012.CrossRef
18.
go back to reference Garcia MN, Aguilar D, Gorchakov R, et al. Evidence of autochthonous chagas disease in southeastern Texas: am J trop med Hyg; 2015.CrossRef Garcia MN, Aguilar D, Gorchakov R, et al. Evidence of autochthonous chagas disease in southeastern Texas: am J trop med Hyg; 2015.CrossRef
20.
go back to reference Klotz SA, Dorn PL, Klotz JH, Pinnas JL, Weirauch C, Kurtz JR, et al. Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease. Acta Trop. 2009;111(2):114–8.CrossRef Klotz SA, Dorn PL, Klotz JH, Pinnas JL, Weirauch C, Kurtz JR, et al. Feeding behavior of triatomines from the southwestern United States: an update on potential risk for transmission of Chagas disease. Acta Trop. 2009;111(2):114–8.CrossRef
21.
go back to reference Eggers P. Notes from the field: identification of a Triatoma sanguisuga “kissing bug”—Delaware, 2018. MMWR Morb Mortal Wkly Rep. 2019;6868(15):359. Eggers P. Notes from the field: identification of a Triatoma sanguisuga “kissing bug”—Delaware, 2018. MMWR Morb Mortal Wkly Rep. 2019;6868(15):359.
22.
go back to reference Curtis-Robles R, Auckland LD, Snowden KF, Hamer GL, Hamer SA. Analysis of over 1500 triatomine vectors from across the US, predominantly Texas, for Trypanosoma cruzi infection and discrete typing units. Infect Genet Evol. 2018;58:171–80.CrossRef Curtis-Robles R, Auckland LD, Snowden KF, Hamer GL, Hamer SA. Analysis of over 1500 triatomine vectors from across the US, predominantly Texas, for Trypanosoma cruzi infection and discrete typing units. Infect Genet Evol. 2018;58:171–80.CrossRef
23.
go back to reference Gorchakov R, Trosclair LP, Wozniak EJ, Feria PT, Garcia MN, Gunter SM, et al. Trypanosoma cruzi infection prevalence and bloodmeal analysis in triatomine vectors of Chagas disease from rural peridomestic locations in Texas, 2013–2014. J Med Entomol. 2016;53(4):911–8.CrossRef Gorchakov R, Trosclair LP, Wozniak EJ, Feria PT, Garcia MN, Gunter SM, et al. Trypanosoma cruzi infection prevalence and bloodmeal analysis in triatomine vectors of Chagas disease from rural peridomestic locations in Texas, 2013–2014. J Med Entomol. 2016;53(4):911–8.CrossRef
24.
go back to reference Wozniak EJ, Lawrence G, Gorchakov R, Alamgir H, Dotson E, Sissel B, et al. The biology of the triatomine bugs native to south Central Texas and assessment of the risk they pose for autochthonous Chagas disease exposure. J Parasitol. 2015;101(5):520–8.CrossRef Wozniak EJ, Lawrence G, Gorchakov R, Alamgir H, Dotson E, Sissel B, et al. The biology of the triatomine bugs native to south Central Texas and assessment of the risk they pose for autochthonous Chagas disease exposure. J Parasitol. 2015;101(5):520–8.CrossRef
25.
go back to reference Garcia MN, O’Day S, Fisher-Hoch S, Gorchakov R, Patino R, Arroyo TPF, et al. One health interactions of Chagas disease vectors, canid hosts, and human residents along the Texas-Mexico border. PLoS Neglected Trop Dis. 2016;10(11):e0005074. Garcia MN, O’Day S, Fisher-Hoch S, Gorchakov R, Patino R, Arroyo TPF, et al. One health interactions of Chagas disease vectors, canid hosts, and human residents along the Texas-Mexico border. PLoS Neglected Trop Dis. 2016;10(11):e0005074.
26.
go back to reference Gunter SM, Murray KO, Gorchakov R, Beddard R, Rossmann SN, Montgomery SP, et al. Likely autochthonous transmission of Trypanosoma cruzi to humans, south Central Texas, USA. Emerg Infect Dis. 2017;23(3):500–3.CrossRef Gunter SM, Murray KO, Gorchakov R, Beddard R, Rossmann SN, Montgomery SP, et al. Likely autochthonous transmission of Trypanosoma cruzi to humans, south Central Texas, USA. Emerg Infect Dis. 2017;23(3):500–3.CrossRef
27.
go back to reference Garcia M, Woc-Colburn L, Rossmann S, Townsend R, Stramer S, Bravo M, et al. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. 2016;144(5):1010–3.CrossRef Garcia M, Woc-Colburn L, Rossmann S, Townsend R, Stramer S, Bravo M, et al. Trypanosoma cruzi screening in Texas blood donors, 2008–2012. Epidemiol Infect. 2016;144(5):1010–3.CrossRef
28.
go back to reference Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019;33(1):e00023–19. Bern C, Messenger LA, Whitman JD, Maguire JH. Chagas disease in the United States: a public health approach. Clin Microbiol Rev. 2019;33(1):e00023–19.
29.
go back to reference Forsyth CJ, Hernandez S, Flores CA, Roman MF, Nieto JM, Marquez G, et al. “It’s like a phantom disease”: patient perspectives on access to treatment for Chagas disease in the United States. Am J Trop Med Hygiene. 2018;98(3):735–41.CrossRef Forsyth CJ, Hernandez S, Flores CA, Roman MF, Nieto JM, Marquez G, et al. “It’s like a phantom disease”: patient perspectives on access to treatment for Chagas disease in the United States. Am J Trop Med Hygiene. 2018;98(3):735–41.CrossRef
30.
go back to reference Tan MT, Matthews KR. Misconceptions and limited awareness of Chagas disease in Texas among surveyed Houston physicians; 2018. Tan MT, Matthews KR. Misconceptions and limited awareness of Chagas disease in Texas among surveyed Houston physicians; 2018.
31.
go back to reference Forsyth C, Meymandi S, Moss I, Cone J, Cohen R, Batista C. Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States. PLoS Neglect Trop Dis. 2019;13(9):e0007447. Forsyth C, Meymandi S, Moss I, Cone J, Cohen R, Batista C. Proposed multidimensional framework for understanding Chagas disease healthcare barriers in the United States. PLoS Neglect Trop Dis. 2019;13(9):e0007447.
32.
go back to reference Bennett C, Straily A, Haselow D, Weinstein S, Taffner R, Yaglom H, et al. Chagas disease surveillance activities—seven states, 2017. Morb Mortal Wkly Rep. 2018;67(26):738.CrossRef Bennett C, Straily A, Haselow D, Weinstein S, Taffner R, Yaglom H, et al. Chagas disease surveillance activities—seven states, 2017. Morb Mortal Wkly Rep. 2018;67(26):738.CrossRef
33.
go back to reference Curtis-Robles R, Wozniak EJ, Auckland LD, Hamer GL, Hamer SA. Combining public health education and disease ecology research: using citizen science to assess Chagas disease entomological risk in Texas. PLoS Neglected Trop Dis. 2015;9(12):e0004235. Curtis-Robles R, Wozniak EJ, Auckland LD, Hamer GL, Hamer SA. Combining public health education and disease ecology research: using citizen science to assess Chagas disease entomological risk in Texas. PLoS Neglected Trop Dis. 2015;9(12):e0004235.
36.
go back to reference Team RC. R: a language and environment for statistical computing; 2013. Team RC. R: a language and environment for statistical computing; 2013.
37.
go back to reference Ebner C, Gegenfurtner A. Learning and satisfaction in webinar, online, and face-to-face instruction: a meta-analysis. Front Educ. 2019;4:92. Ebner C, Gegenfurtner A. Learning and satisfaction in webinar, online, and face-to-face instruction: a meta-analysis. Front Educ. 2019;4:92.
38.
go back to reference LeCloux M. The development of a brief suicide screening and risk assessment training webinar for rural primary care practices. J Rural Ment Health. 2018;42(1):60.CrossRef LeCloux M. The development of a brief suicide screening and risk assessment training webinar for rural primary care practices. J Rural Ment Health. 2018;42(1):60.CrossRef
39.
go back to reference Wang S-K, Hsu H-Y. Use of the webinar tool (Elluminate) to support training: the effects of webinar-learning implementation from student-trainers’ perspective. J Interactive Online Learning. 2008;7(3):175–94. Wang S-K, Hsu H-Y. Use of the webinar tool (Elluminate) to support training: the effects of webinar-learning implementation from student-trainers’ perspective. J Interactive Online Learning. 2008;7(3):175–94.
40.
go back to reference Johnson CL, Schumacher JB. Does webinar-based financial education affect knowledge and behavior? J Ext. 2016;54(1):n1. Johnson CL, Schumacher JB. Does webinar-based financial education affect knowledge and behavior? J Ext. 2016;54(1):n1.
41.
go back to reference Liu Q, Peng W, Zhang F, Hu R, Li Y, Yan W. The effectiveness of blended learning in health professions: systematic review and meta-analysis. J Med Internet Res. 2016;18(1):e2.CrossRef Liu Q, Peng W, Zhang F, Hu R, Li Y, Yan W. The effectiveness of blended learning in health professions: systematic review and meta-analysis. J Med Internet Res. 2016;18(1):e2.CrossRef
42.
go back to reference Choules A. The use of elearning in medical education: a review of the current situation. Postgrad Med J. 2007;83(978):212–6.CrossRef Choules A. The use of elearning in medical education: a review of the current situation. Postgrad Med J. 2007;83(978):212–6.CrossRef
43.
go back to reference Rouse D. The effectiveness of computer-assisted instruction in teaching nursing students about congenital heart disease. Comput Nurs. 2000;18(6):282–7.PubMed Rouse D. The effectiveness of computer-assisted instruction in teaching nursing students about congenital heart disease. Comput Nurs. 2000;18(6):282–7.PubMed
44.
go back to reference Ramos-Rincón JM, Mira-Solves JJ, Ramos-Sesma V, Torrús-Tendero D, Llenas-García J, Navarro M. Healthcare Professionals and Students’ Awareness of Chagas Disease: Design and Validation of Chagas Level of Knowledge Scale. Am J Trop MedHygiene. 2020;103(1):437–44. Ramos-Rincón JM, Mira-Solves JJ, Ramos-Sesma V, Torrús-Tendero D, Llenas-García J, Navarro M. Healthcare Professionals and Students’ Awareness of Chagas Disease: Design and Validation of Chagas Level of Knowledge Scale. Am J Trop MedHygiene. 2020;103(1):437–44.
Metadata
Title
Assessing the effectiveness of Chagas disease education for healthcare providers in the United States
Authors
Paula Stigler Granados
Gerardo J. Pacheco
Evangelina Núñez Patlán
Jose Betancourt
Lawrence Fulton
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05474-w

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.